Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1467144

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sexual Assault Referral Centres: Domestic Abuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the new specific offence of strangulation and suffocation in the Domestic Abuse Act 2021, whether victims of those crimes in a domestic abuse setting will be able to access sexual assault referral centres.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	11698
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p>Sexual Assault Referral Centres (SARCs) are available 24 hours a day, seven days a week to all victims and survivors of sexual violence and abuse irrespective of age, gender or when the assault or abuse occurred.  NHS England and NHS Improvement will review service provision to determine whether forensic and medical interventions for non-fatal strangulation should form part of the core offer for SARCs.</p><p> </p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 08/06/2022 16:20:28 answering member 4680 label Biography information for Gillian Keegan
tabling member	4370 label Biography information for Jess Phillips

1467145

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Incentives
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of allowing senior academic General Practitioners to access clinical excellence awards.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	11720
answer	answer is ministerial correction date of answer 13/06/2022 answer text <p>The National Clinical Excellence Awards have been reformed and renamed the National Clinical Impact Awards. Academic general practitioners (GPs) are eligible to apply for an award if they meet the criteria within the 2022 guidance for applicants, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/clinical-excellence-awards-application-guidance/guide-for-applicants-national-clinical-excellence-awards-2021-awards-round" target="_blank">https://www.gov.uk/government/publications/clinical-excellence-awards-application-guidance/guide-for-applicants-national-clinical-excellence-awards-2021-awards-round</a></p><p>Access to the Local Clinical Excellence Award scheme is a contractual entitlement for all consultants employed on the 2003 terms and conditions. Academic GPs are not eligible for the scheme as they are employed on separate terms and conditions.</p><p><strong> </strong></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 13/06/2022 15:08:19 answering member 4362 label Biography information for Edward Argar
tabling member	4433 label Biography information for Thangam Debbonaire

1467186

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many women received Hormone Replacement Therapy prescriptions for (a) utrogestan, (b) body-identical oestrogen patches and gels, (c) non-body-identical oestrogen, (d) non-body identical progestogens and (d) the testosterone products (i) testogel, (ii) testim and (iii) tostran in each of the last ten years by Parliamentary constituency or the lowest available administrative level if that data is not available.
tabling member constituency	Swansea East
tabling member printed	Carolyn Harris
uin	11760
answer	answer is ministerial correction date of answer 07/07/2022 answer text <p>The information is not held in the format requested.</p><p> </p><p>The attached table shows items dispensed in the community at clinical commissioning group level in England from 2015/16 to 2021/22.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 07/07/2022 15:52:03 answering member 4492 label Biography information for Maria Caulfield attachment 1 file name FORMATTED TABLE FOR MINISTERIAL CLEARANCE PQ11760 Data.xlsx title TABLE
tabling member	4480 label Biography information for Carolyn Harris

1467192

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will convene a dementia medicines taskforce to accelerate the development of new medicines.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	11834
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p>Officials have met Alzheimer’s Research UK to discuss the proposal for a Dementia Medicines Taskforce. We are currently considering the merits of the proposal to accelerate patient access to medicines with NHS England and NHS Improvement We will set out plans for dementia in England for the next 10 years later this year, including on diagnosis, risk reduction and prevention and research. The strategy will include ambitions for research to develop new disease-modifying treatments.</p><p> </p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 08/06/2022 16:23:20 answering member 4680 label Biography information for Gillian Keegan
tabling member	4651 label Biography information for Dan Carden

1467193

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will expand access to the spring booster vaccination programme to people with motor neurone disease.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	11835
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p>During the spring booster vaccination programme, an additional dose is being offered to residents in care homes for older adults, individuals aged 12 years old and over who are immunosuppressed and adults aged 75 years old and over. The Joint Committee on Vaccination and Immunisation (JCVI) do not currently recommend a further dose for those with motor neurone disease, unless the existing criteria applies.</p><p>The JCVI continues to consider the latest available data, particularly in relation to the timing and value of any further doses. On 19 May 2022, the JCVI published interim advice on an autumn COVID-19 booster programme. The JCVI advises that a booster dose should be offered to residents in care homes for older adults and staff; frontline health and social care workers; all those aged 65 years old and over; and adults aged 16 to 64 years old who are in a clinical risk group, such as motor neurone disease.</p><p>The JCVI will continue to review the vaccination programme, the definitions of clinical risk groups and the epidemiological situation to inform its final advice. The Government will consider the JCVI's final advice before determining which groups should be included in the autumn COVID-19 booster programme.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 08/06/2022 08:15:44 answering member 4447 label Biography information for Maggie Throup
tabling member	4651 label Biography information for Dan Carden

1467199

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the effectiveness of measures to protect people who are most vulnerable from covid-19; and whether he plans to make an assessment of the potential merits of implementing such measures.
tabling member constituency	Broxtowe
tabling member printed	Darren Henry
uin	11888
answer	answer is ministerial correction date of answer 13/06/2022 answer text <p>The UK Health Security Agency’s COVID-19 vaccine surveillance report shows that as of 21 April 2022, vaccine uptake among those identified as severely immunosuppressed was 95.7% for at least one dose, 94.5% for at least two doses and 88.1% for at least three doses. NHS England’s COVID Therapeutics data for the week ending 22 May 2022 shows that the number of non-hospitalised people in England who have received antivirals or neutralising monoclonal antibody treatments is 45,745. The Office for National Statistics’ survey ‘Coronavirus and clinically extremely vulnerable people in England’ published on 13 May shows that 81% of respondents were aware of guidance for people whose immune system means they are at higher risk. We have no plans to make a further assessment of the current measures which are in place.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 13/06/2022 15:21:38 answering member 4447 label Biography information for Maggie Throup
tabling member	4794 label Biography information for Darren Henry

1467201

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, in what ways and to what extent the update to the NHS Long Term Plan will support the diagnosis of people with dementia.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	11578
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p><strong> </strong></p><p>Discussions on the detail of the updated NHS Long Term Plan are continuing.</p><p> </p><p>We will set out plans for dementia in England for the next 10 years later this year, including the specific health and care needs of people living with dementia and their carers, such as diagnosis, risk reduction and prevention and research.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 11579 question first answered 08/06/2022 16:18:49 answering member 4680 label Biography information for Gillian Keegan
tabling member	1506 label Biography information for Andrew Gwynne

1467202

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the update to the NHS Long Term Plan will strengthen the NHS's focus on the (a) diagnosis, (b) treatment and (c) care for people with dementia.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	11579
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p><strong> </strong></p><p>Discussions on the detail of the updated NHS Long Term Plan are continuing.</p><p> </p><p>We will set out plans for dementia in England for the next 10 years later this year, including the specific health and care needs of people living with dementia and their carers, such as diagnosis, risk reduction and prevention and research.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 11578 question first answered 08/06/2022 16:18:49 answering member 4680 label Biography information for Gillian Keegan
tabling member	1506 label Biography information for Andrew Gwynne

1467203

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the covid-19 outbreak on rates of dementia diagnosis; what steps he plans to take through the upcoming Dementia Strategy to tackle any backlog in dementia diagnosis; and if he will make a statement.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	11580
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p>The pandemic had a significant impact on access to memory assessment services and general practitioner referrals due to re-prioritisation of services and the guidance for older people to shield at home. As of April 2022, the dementia diagnosis rate had recovered to 61.8%.</p><p> </p><p>We will set out plans for dementia in England for the next 10 years later this year, including a focus on dementia diagnosis.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 08/06/2022 16:21:12 answering member 4680 label Biography information for Gillian Keegan
tabling member	1506 label Biography information for Andrew Gwynne

1467221

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Mortality Rates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the 10 Year Cancer Plan will include a strategy to improve pancreatic cancer survival rates; and what steps his Department is taking to ensure improved survival rates from pancreatic cancer.
tabling member constituency	North East Bedfordshire
tabling member printed	Richard Fuller
uin	11638
answer	answer is ministerial correction date of answer 13/06/2022 answer text <p><strong> </strong></p><p>I refer the hon. Member to the answer I gave to the hon. Member for Scunthorpe (Holly Mumby-Croft MP) on 24 May 2022 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2022-05-17/3800" target="_blank">3800</a>.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/06/2022 14:29:53 answering member 4492 label Biography information for Maria Caulfield
tabling member	3912 label Biography information for Richard Fuller